KalVista Pharmaceuticals
Kurt Dr. Kamalioglu is a seasoned professional in business insights and analytics currently serving as the Senior Director European Business Insights & Analytics Lead at KalVista Pharmaceuticals, Inc. since March 2024. Previously, Kurt held key positions at Takeda, including Director of Global Forecasting & Analytics Lead, where extensive experience was gained in enabling data-driven strategies and leading global forecasting teams. Additional roles at Takeda involved developing strategic insights for marketing programs in the rare metabolic disease and rare hematology franchises. Kurt's career in the pharmaceutical industry also includes senior managerial positions at Shire and Bayer Pharmaceuticals, where expertise in market research and competitive intelligence was demonstrated. Kurt began the career in pharmaceutical sales before advancing into market research and holds a Doctor of Chemistry degree from FAU Erlangen-Nürnberg.
This person is not in any teams
This person is not in any offices
KalVista Pharmaceuticals
2 followers
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases....